The Jinling Cohort: An Observational Study of MCED Blood Test
Recruiting NCT06011694
Study Description
Evaluating the Performance of a Multi-omics Cancer Early Detection (MCED) Blood Test in an Average Risk Chinese Population
Study Details
- Registry ID:
- NCT06011694
- Conditions:
- Cancer, Multi Cancer Early Screening, Liquid Biopsy
- Phase:
- Target Enrollment:
- 15,000 participants
- Start Date:
- Age Range:
- 45–75 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Nanjing Jiangbei People's Hospital
Nanjing, Jiangsu, China -
The Fourth Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.